Co-immunoprecipitation experiments have revealed that ECA can directly bind to the LEF-1 protein in SW480 colon cancer cells [39,122] and destabilize the LEF-1-β-catenin complex, thereby interfering with its formation with β-catenin. Here, LEF1 is linked to malignant colon neoplasm.